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Introduction:
Exome sequencing has transformed gene discovery in autism spectrum disorder (ASD).
Observing multiple de novo protein truncating variants (PTVs, e.g. premature stop codons) in a gene demonstrates ASD association (1) and, to date, 65 such ASD genes have been identified (2) (3) (4) . The gene SCN2A, which encodes the sodium channel Na V 1.2, was one of the first ASD genes identified (1) and remains one of the genes with the strongest evidence for association with ASD (2) and, recently, developmental delay (5) . SCN2A stands out from other ASDassociated genes in several ways. First, while most ASD-associated genes are related to either chromatin regulation or synapse structure (2), Na V 1.2 channels are primarily expressed in the axon (6) (7) (8) (9) (10) . Second, along with de novo PTVs, an excess of de novo missense mutations is also observed in SCN2A, a pattern seen in no other gene (2) . Finally, genetic variants in SCN2A have previously been associated with infantile seizures, ranging from benign infantile familial seizures (BIFS) to epileptic encephalopathy (EE) with poor developmental outcome (11) , however only 4 of 19 ASD patients for whom phenotypic data were available had a history of seizures and none had infantile seizures (Table S1 in Supplement 2). Na V 1.2 channels support central functions in developing and mature neurons, particularly in cortical glutamatergic pyramidal cells (6, 7) that are a locus of dysfunction in ASD (12) (13) (14) . During early development, Na V 1.2 is the only Na V isoform expressed at nodes of Ranvier and in the axon initial segment (AIS) (15) (16) (17) , the site of action potential initiation in most neurons (18, 19) . Na V 1.2 is therefore critical for AP generation and propagation as these neurons integrate into circuits. Later in development, Na V 1.2 is replaced by Na V 1.6 (SCN8A), which has a lower voltage threshold for activation, at the majority of nodes and in the distal AIS (7, 10) . Consequently, AP initiation occurs in this Na V 1.6-rich region in mature neurons (19, 20) , and Na V 1.2, now restricted to the proximal AIS, takes on a new role, boosting rather than initiating APs (6) . This developmental transition in AIS distribution may explain the resolution of seizures observed in BIFS before two years of age (13) .
The majority of SCN2A missense variants associated with infantile seizures in BIFS and EE are gain of function (7, (21) (22) (23) (24) (25) ; but see 26) . In contrast, mutations observed in ASD/developmental delay are either PTVs resulting in loss of Na V 1.2 function or missense mutations of unknown effect. These observations raise the hypothesis that SCN2A variants exert opposing effects on Na V 1.2 function in infantile seizures and ASD.
Here, we used bioinformatics, electrophysiology, and compartmental modeling to test how different SCN2A variants affect the function of Na V 1.2 channels. We report that the majority of missense mutations observed in ASD completely blocked channel conductance, while the remainder altered Na V 1.2 biophysical properties in ways that dampened channel function.
Regardless of mechanism, all ASD-related variants impaired neuronal excitability in computational models of developing pyramidal cells. These impairments largely resolved as Na V 1.6 replaced Na V 1.2 in the distal AIS of mature models, supporting the notion that ASD is a consequence of disruption to early brain development leading to persistent neurodevelopmental dysfunction (27) . Results from these de novo missense mutations in eight individuals, along with four individuals with de novo PTVs, identify SCN2A mutations in 0.3% of ASD cases (12 out of 4,109 cases with exome data). SCN2A therefore has the strongest evidence of ASD association of any gene discovered by exome sequencing, and is the most frequent single gene contributor to ASD, after Fragile X mutations.
Methods:
Briefly, wild type and variants of SCN2A harboring an ASD-associated mutation were cotransfected with β1-β2 subunits in HEK293 cells. Sodium channel function was assessed with voltage-clamp techniques and immunohistochemistry, and then incorporated into a pyramidal cell computational model. Please see Supplemental Methods for details.
Results:
A comprehensive literature review identified 148 SCN2A variants (117 unique) in 148 families (Table S1 in Similarly, variants observed in EE are mainly missense variants (49/51, 96%) along with one 2.6Mbp duplication and one PTV; however, unlike BIFS variants, most are de novo (48 of 49 with inheritance data, 98%). EE missense variants also cluster in and between the transmembrane segments (39/49; 2-fold enrichment; p=2x10 -6 , binomial test; Fig. 1A ), particularly segments 4 and 5 (24/49; 4-fold enrichment; p=4x10 -10 , binomial test; Fig. 1A ). While the variants in BIFS and EE cluster in similar domains of the Na v 1.2 protein, there are no examples of a variant contributing to both disorders, despite multiple recurrent variants in different families being observed in both BIFS (3xR1319Q) and EE (4xR853Q, 3xE999K, 3xL1342P, 3xR1882Q). Seven BIFS and three EE variants have been characterized electrophysiologically (Table S1 , S2 in Supplement 2), largely revealing gain of function thought to result in neuronal hyperexcitability (7, (21) (22) (23) (24) (25) (but see 26) .
In contrast to BIFS and EE, over half of the ASD-associated variants are predicted to prevent translation of one SCN2A allele, with 12 PTVs and 2 deletions (14/27, 52%). ExAC (28) and RVIS (29) , two methods that use large-scale population data to identify constrained genes that are intolerant of deleterious variation, both predict that SCN2A is highly intolerant of such haploinsufficiency, with 30-fold fewer PTVs observed in an adult population than expected.
Consistent with a highly deleterious effect, all PTV and deletion variants are de novo (13/13 for which data are available, Table S1 in Supplement 2). The remaining 13 (48%) variants in ASD cases are missense (Table S1 in Supplement 2) and most of these are also de novo (12/13, 92%). Unlike the missense variants in BIFS and EE, ASD-missense variants cluster in the pore loop that forms the sodium ion selectivity filter (8/13; 3.8-fold enrichment; p=0.0004 binomial test; Fig. 1B and 1C) , particularly in the five amino acid residues that line the pore upstream of the ion selectivity filter (3) (6/13; 33-fold enrichment; p=1x10 -8 binomial test; Fig. 1C ). Many individuals with ASD have co-existing intellectual disability ( Fig. 1D ) and developmental delay ( Sequencing Consortium (ASC; 1,601 families with one or more affected children), as these cases were identified as representing idiopathic ASD in clearly defined cohorts (4, 9, 22) .
To confirm that PTV SCN2A mutations indeed impair Na V 1.2 channel formation, and to determine whether missense mutations alter channel function, we made voltage-clamp recordings from HEK293 cells expressing wild type (WT) or mutated channels. β1 and β2
subunits were co-expressed in all experiments. As predicted, nonsense (p.C959X, p.G1013X) and frameshift (p.S686fs) PTVs lacked Na + currents ( Fig. 2A-B ). Constructs recapitulating a fourth PTV that disrupts a canonical splice site in SCN2A (c.4821-1A>T) were not studied here,
as it was unclear whether the mRNA recombines after this splice event. The missense mutations produced a range of results. Peak currents from D12N-mutated channels were comparable in size to wild type (WT: -447±45 pA/pF, n=18; D12N: -515±65 pA/pF, n=16; p=0.5), while currents from D82G and T1420M variants were smaller than wild type (D82G: -166±32
pA/pF, n=18, p<0.0001 vs WT; T1420M: -177±22 pA/pF, n=13, p<0.0001 vs WT). Remarkably, all other missense mutations, including pore-localized arginine mutations observed in multiple ASD cases (R379, R937), resulted in a loss of Na V 1.2 function. Small residual currents were observed, but these were likely generated by endogenously expressed nonselective cation channels (30), as they were observed in all PTV cases (where no channel was formed but the plasmid vector still expressed GFP) and in untransfected cells (Fig. 2B) . Furthermore, no current was observed when using a K + -based intracellular solution, indicating that these channels are not permeable to K + . Despite the lack of current, non-conducting missense mutations still allowed for Na V 1.2 channel formation and trafficking, as membrane-associated Na V 1.2 staining was evident using confocal and total internal reflectance fluorescence (TIRF) microscopy ( Fig. S2 in Supplement 1). Thus, of the 12 ASD-variants tested here, 9 (75%) resulted in a complete loss of Na V 1.2 conductance (Fig. 1B, 2B ). Multiple lines of evidence suggest that disruption in neocortical circuits can contribute to infantile seizures and ASD (3, 30, 32, 34) . To test how dysfunction in Na V 1.2 affects neuronal excitability, we incorporated each type of Na V 1.2 mutation observed into an established computational model of a cortical pyramidal cell (35) . Because the mutations observed in ASD are heterozygous, we incorporated equal amounts of wild type and mutated channels into the model and incorporated changes to the affected allele based on results in Fig. 2 (see Methods).
To validate that these models accurately predict changes in neuronal excitability, and to compare ASD mutations with other conditions (Fig. 1) , BIFS and EE variants were also modeled. These include L1563V and L1330F, which are associated with BIFS and produce modest (~5 mV) shifts in steady state voltage dependence (24) , and E1211K and I1473M, which are associated with EE and produce larger (14-22 mV) changes in voltage dependence (23) .
As pyramidal neurons are incorporating into cortical networks during early development, they express only Na V 1.2 in the AIS (15) (16) (17) , and it is thought that SCN2A variants associated with BIFS produce seizures because Na V 1.2 plays the dominant role in neuronal excitability at this age (7) . This time period may also be critical for ASD, as the early development of prefrontal layer 5/6 pyramidal cells has been implicated in the disorder (13) . Therefore, we created a developmental model in which Na V 1.2 was expressed throughout the AIS and axon and a mature model in which Na V 1.2 was replaced by Na V 1.6 in the distal AIS and axon. In control conditions, spike threshold was depolarized in the developmental model relative to the mature model, consistent with the differences in voltage-dependent activation between the two isoforms ( Fig. 3 ; Fig. S3 in Supplement 1). Intermediary developmental timepoints with different densities or distributions of Na V 1.2 vs Na V 1.6 were also modeled ( Fig. S4 in Supplement 1).
In the developmental model, BIFS variants hyperpolarized spike threshold and enhanced in spike rate, consistent with seizure phenotypes at this early age. EE variants were more excitable, firing spikes even at rest. In contrast, ASD variants were far less excitable than wild type. Full PTV/non-conducting missense models had a rheobase spike threshold 7 mV more depolarized than WT conditions. Similarly, spike threshold in models of D12N, D82G, and T1420M variants was depolarized to levels comparable to a 40-50% reduction in overall Na V 1.2 conductance. In all cases, spike rate was suppressed, suggesting that even though missense mutations have different effects on Na V 1.2 channels, they produce comparable deficits in neuronal excitability. Therefore, all 12 of the observed ASD variants were predicted to reduce the excitability of cortical pyramidal neurons during early development.
In the mature model, BIFS variants had only modest effects on threshold or spike rate, whereas EE variants still resulted in marked hyperexcitability. This is consistent with seizure resolution in BIFS, but not in EE. Interestingly, the ASD variants also resulted in minimal changes in neuronal excitability. Mature excitability developed gradually as more Na V 1.6 was incorporated into the AIS (Fig. S4 in Supplement 1). Overall, this suggests that the critical period for SCN2A mutations to produce an ASD phenotype through changes in neuronal excitability occurs during early development.
Discussion:
Mutations in SCN2A are strongly associated with both ASD and infantile seizures. Here, we characterized the functional impact of all 11 de novo mutations in SCN2A from ASD cases in the Simons Simplex Collection and Autism Sequencing Consortium. All three PTVs (i.e.
nonsense and frameshift) and the majority of missense mutations resulted in a complete loss of Na V 1.2 function, despite normal trafficking to the membrane ( Several more were observed within the pore at conserved arginine residues (R379, R937).
These residues are notable, as mutations here are the only instance of two de novo missense mutations occurring at the same residue in two different families among 4,109 cases with exome data (2) . Two missense mutations located on the N-terminal domain altered inactivation kinetics (D12N) and the voltage dependence of steady-state activation (D82), demonstrating, to our knowledge, the first examples of pathological N-terminal mutations in Na V 1.2 (37) . T1420M, which is in close proximity to the pore selectivity filter (Fig. 1) , also had deleterious effects on channel function, increasing the speed of inactivation and reducing functional (Fig. 2G ) and physical channel surface density (Fig. S2C-D) . Mutation of a homologous residue in rat Na V 1.4
to cysteine had modest effects on channel function (38) , suggesting that the observed change in pore hydrophobicity is critical at this residue.
Since all SCN2A mutations analyzed led to haploinsufficiency, including all missense variants characterized here, we can revise our estimate of the contribution of SCN2A mutations to ASD risk. Across the 4,109 ASD cases, 12 (0.29%) have mutations resulting in SCN2A
haploinsufficiency, a figure marginally higher than that for CHD8 (0.24% if equivalent functional analyses validated three non-PTV mutations along with the seven PTV mutations), making SCN2A the gene with the strongest evidence for ASD-association based on exome analysis and second only to Fragile X Syndrome as a single gene cause of ASD. Therefore, examination of the neurobiology consequent to SCN2A haploinsufficiency, alongside parallel analysis of genes related to chromatin regulation, synaptic structure, and Fragile X Syndrome, is likely to provide critical insights into the etiology of ASD.
Modeling ASD-associated SCN2A mutations in pyramidal neurons predicted a reduction in neuronal excitability in the developing brain in which Na V 1.2 is present throughout the AIS and axon, but minimal changes in neuronal excitability in the mature brain in which Na V 1.2 is restricted to the proximal AIS (Fig. 3) . If neuronal excitability were the main physiological consequence of reduced Na V 1.2 function, this would imply that the contribution of SCN2A mutations to the ASD phenotype occurs primarily during early development. Of note, pyramidal cortical neurons during mid-fetal development have previously been implicated in ASD through co-expression networks (13) . Since the ASD phenotype persists in the mature brain, the decrease in neuronal excitability would need to result in a downstream change that persists after neuronal excitability returns to physiological levels. Examples of such a downstream effect include the formation and maturation of cortical circuits and the balance of excitatory and inhibitory inputs within these circuits (39, 40) .
Alternatively, Na V 1.2 dysfunction may continue to affect circuits even after these early developmental time periods in a manner not simulated in our model. APs initiated in the distal AIS propagate forwards, towards axonal release sites, and backwards, throughout the soma and dendrites (backpropagation). In mature pyramidal cells, Na V 1.2 channels in the proximal AIS are thought to provide an important electrical boost to promote effective backpropagation of APs into the somatodendritic compartment (6) and this function may still be impaired in the mature cell. Backpropagating spikes are critical signals for activity-dependent transcription, dendritic integration, and synaptic plasticity (41, 42) . In this way, mutations in SCN2A may interact with other ASD-associated mutations at the synapse (43, 44), or at the transcriptional level. Thus, even though Na V 1.2 channels are restricted to the axon, SCN2A haploinsufficiency may result in cellular and circuit dysfunctions that may be common to other causes of ASD.
In contrast to ASD, the SCN2A variants observed in infantile seizures have a gain of function effect on Na V 1.2. Computational models showed that variants observed in BIFS result in increased neuronal excitability during early development, but not in the mature brain (Fig. 3) , consistent with the observed resolution of infantile seizures without further apparent neurological impairment (Table S1 in Supplement 2). The variants characterized in EE are predicted to result in a greater degree of neuronal excitability that persists in the mature brain (Fig. 3) . This is consistent with the severe seizure phenotype that often persists beyond infancy and is accompanied by profound neurological impairment from an early age (Table S1 in Supplement 2).
Numerous genetic loci associated with neuropsychiatric disorders are observed across a range of diagnoses including developmental delay, ASD, and schizophrenia. Previously, correlation between phenotype and genotype has been described for some large-scale recurrent deletions and duplications (2, 45) . Here, we show that functional analysis of apparently similar SCN2A missense mutations (Fig. S1 in Supplement 1) can distinguish two neuropsychiatric phenotypes: infantile seizures and ASD/developmental delay, with further correlation between functional severity and phenotypic severity for infantile seizures (Fig. 3) .
Thus, the specific functional effect of each SCN2A mutation is directly affecting the observed neuropsychiatric phenotype, presumably with genetic background, environmental influences, and stochastic effects also playing a modifying role. It remains to be seen if further functional characterization can distinguish more closely related phenotypes such as ASD and intellectual disability (Fig. 1D ).
While we focused on understanding Na V 1.2 dysfunction in cortical pyramidal cells, SCN2A expression in other cell types may also contribute to ASD. Though the majority of cortical interneurons express SCN1A/Na V 1.1 at the AIS (46, 47) , with loss of function resulting in Dravet Syndrome with EE (48), somatostatin positive interneurons, which play a role in cortical circuit maturation (49, 50) , express a mix of both Na V 1.1 and 1.2 in the proximal AIS (9) .
Further, Na V 1.2 channels are expressed throughout cerebellar granule cell axons (8) , potentially contributing to episodic ataxia (25) . Consequently, further functional studies, including in vivo models expressing specific SCN2A variants, will be required to fully understand the pathophysiological consequences of deleterious SCN2A variants. Nevertheless, the comprehensive functional assessment of ASD-associated mutations alongside the existing literature on SCN2A variation and electrophysiology (Table S1 in (Fig. 1A) . In contrast, our analysis shows that variants observed in ASD are usually de novo and lead to loss of function by introducing a premature stop codon (PTV) or by disrupting the pore loop and possibly the N-terminus (Fig. 1B) . These variants lead to loss of function in Na V 1.2 ( Fig. 2) , resulting in reduced neuronal excitability during development only (Fig. 3) . We predict that this defect in neuronal excitability would result in a persistent change in neuronal circuitry or activity that would converge with neurobiological changes observed following disruption of ASDassociated chromatin regulating or synaptic genes. B. Same as A, but in a mature pyramidal cell model, with a mix of Na V 1.2 and Na V 1.6 in the AIS, and Na V 1.6 in the axon (see Fig. S3 in Supplement 1 for distributions).
C. Spike threshold with varying levels of Na V 1.2 in the AIS, from WT (100%) through different levels of compensation in cells heterozygous for PTV/non-conducting missense variants (to 50%), conducting missense ASD, BIFS, and EE variants. Colored scale bar corresponds to spike threshold of the first spike observed in each trace; dark blue are conditions in which no spikes were generated. Note different scaling for EE conditions, as these variants were excitable at/near rest.
